Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Global Stock · MFS

MFS Global Total Return Fund R6 (MFWLX)

Ticker MFWLX · · Holdings as of Jul 31, 2026

Expense ratio
0.77%$77/yr per $10k
5-yr return
+5.4%annualized
1-yr return
+16.1%as of Dec 2025
Net assets
$1.2Ball share classes
Holdings
970

Bottom line

Is MFWLX a good fund? The bottom line

MFWLX is the R6 share class of MFS Global Total Return Fund, a managed global stock mutual fund from MFS.

Its expense ratio is 0.77% — about $77 a year on every $10,000 invested, cheaper than 72% of global stock funds we track.

It returned +16.1% over one year, +5.4% a year over five years, +6.8% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.2 billion in net assets and 970 holdings, its largest position is Pfizer, Inc. (1.3%) and the top 10 make up 12.5% of the portfolio.

What stands out

  • Broadly diversified (970 holdings)
  • No front-end sales load

Updated Nov 19, 2026

What MFWLX invests in

The funds investment objective is to seek total return.

MFS (Massachusetts Financial Services Company, the funds investment adviser) invests the funds assets in equity securities and debt instruments. Equity securities include common stocks, depositary receipts, and other securities that represent an ownership interest (or right to acquire an ownership interest) in a company or other issuer. Debt instruments include corporate debt instruments, foreign government securities, U.S. Government securities, securitized instruments (including mortgage-backed securities and other asset-backed securities) and other obligations to repay money borrowed. MFS generally invests approximately 60% of the funds assets in equity securities and approximately 40% of the fund's assets in debt instruments. These weightings do not reflect the fund's cash balance and can vary over time due to market movements and cash flows. Of the fund's investments in equity…

From the fund's prospectus (filed Feb 26, 2026).

MFWLX performance

Average annual total returns
1 yr5 yr10 yr
MFWLX+16.1%+5.4%+6.8%
Global Stock median+15.2%+7.6%+9.5%

Source: Fund prospectus, as of Dec 31, 2025

Full MFWLX performance history →

What MFWLX costs

On a $10,000 investment, MFWLX's 0.77% expense ratio costs about $77 a year. The prospectus estimates $1,052 in total costs over 10 years (assuming 5% annual returns). The median global stock fund charges 0.95%.

See the full MFWLX fee table →

MFWLX top 10 holdings

#Holding% of fund
1Pfizer, Inc.1.34%
2Charles Schwab Corp. (The)1.31%
3Northern Trust Corp.1.28%
4Cigna Group (The)1.28%
5NatWest Group plc1.27%
6UBS Group AG1.25%
7BNP Paribas SA1.24%
8Eni SpA1.21%
9Microsoft Corp.1.18%
10MFS Institutional Money Market Portfolio1.16%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 12.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to MFWLX

More funds like MFWLX →

MFWLX FAQ

What is the expense ratio of MFWLX?
MFWLX's expense ratio is 0.77%, which works out to about $77 a year for every $10,000 invested. The prospectus estimates total costs of $1,052 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MFWLX a good investment?
It depends on your goals, but the data points to: broadly diversified (970 holdings); no front-end sales load. This is general information, not personalized advice.
What does MFWLX hold?
MFWLX's largest holdings are Pfizer, Inc. (1.3%), Charles Schwab Corp. (The) (1.3%), Northern Trust Corp. (1.3%), Cigna Group (The) (1.3%), NatWest Group plc (1.3%). It holds 970 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is MFWLX's 5-year return?
MFWLX returned +5.4% a year over the five years ending Dec 31, 2025, and +6.8% a year over ten years. Past performance does not guarantee future results.
Does MFWLX have a sales load?
No. MFWLX has no front-end sales charge.
Who manages MFWLX?
MFWLX is offered by MFS through Mfs Series Trust Vi.